NCT00765908

Brief Summary

This study aims to assess the potential for ischaemic peri-conditioning (IP) in elective percutaneous coronary intervention (PCI) patients to attenuate ischaemia in an animal model of myocardial infarct.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at P25-P50 for phase_1 coronary-artery-disease

Timeline
Completed

Started Oct 2008

Shorter than P25 for phase_1 coronary-artery-disease

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2008

Completed
Same day until next milestone

Study Start

First participant enrolled

October 1, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 3, 2008

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2009

Completed
Last Updated

October 3, 2008

Status Verified

August 1, 2008

Enrollment Period

1 year

First QC Date

October 1, 2008

Last Update Submit

October 2, 2008

Conditions

Outcome Measures

Primary Outcomes (1)

  • Attenuation of infarct size and improved post-ischemia haemodynamic recovery in rat hearts.

    immediate

Secondary Outcomes (1)

  • Clinical endpoints: (i) induction of IP, defined as a minimum 33% reduction in magnitude of ST segment deviation in the territory of the affected artery between the first and second balloon inflation. (ii) Reduction in CK rise post procedure.

    immediate

Study Arms (2)

A

EXPERIMENTAL

Patients undergoing elective PCI will be randomised to 90 second balloon inflations rather than the standard less than 30 second inflations in order to induce peri-ischaemic conditioning.

Device: Angioplasty balloon

B

ACTIVE COMPARATOR

Control group. These patients will have a standard procedure with balloon inflations of 30 seconds or less as per standard.

Device: Angioplasty balloon

Interventions

90 second balloon inflation x 2

A

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability to give written informed consent.
  • All patients who are listed for elective PCI of at least one major epicardial artery.
  • Patients ≥ 18 years and ≤80 years of age.

You may not qualify if:

  • Any patient who has experienced chest pain within the preceding 24 hrs
  • Any patient who exhibits haemodynamic instability (systolic BP \<90mmHg, pulmonary oedema);
  • Any patient with electrophysiologic instability (arrythmias eg rapid AF) or an abnormal baseline electrocardiogram (ECG) (e.g., significant ST segment depression, left bundle-branch block) which precludes analysis of the ST segment shift during PCI
  • Patients unable to give informed consent
  • Diabetes
  • Uncontrolled hypertension (BP\>180/110).
  • Anaemia (Hb \<10g/l).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Angioplasty, Balloon

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

AngioplastyCatheterizationTherapeuticsEndovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresInvestigative Techniques

Study Officials

  • Vladimir Dzavik, MD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vladimir Dzavik, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 1, 2008

First Posted

October 3, 2008

Study Start

October 1, 2008

Primary Completion

October 1, 2009

Study Completion

October 1, 2009

Last Updated

October 3, 2008

Record last verified: 2008-08